ÂÜÀòÂÒÂ×

Mark Spahr is a highly experienced research and development scientist with a focus on discovery biology and assay development. Currently serving as a Research and Development Scientist III at ARBOR ASSAYS and a Senior Research Associate at IFM Therapeutics, Mark has also held positions including Senior Research Scientist at Lycera and Senior Scientist at Esperion Therapeutics. Previous roles include technical support at Cayman Chemical and a Senior Scientist position at Pfizer Global Research and Development, where Mark managed teams and contributed significantly to data generation for project decision-making. Mark began their career as a Staff Immunologist at Merck & Co., showcasing expertise in designing novel assays for cellular activation. Mark holds a Master’s degree in Microbiology and Immunology from the University of Michigan.